184 related articles for article (PubMed ID: 15967080)
1. Molecular prognostic factors in diffuse large B-cell lymphoma.
Morgensztern D; Lossos IS
Curr Treat Options Oncol; 2005 Jul; 6(4):269-77. PubMed ID: 15967080
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B cell lymphoma: from gene expression profiling to prediction of outcome.
Lossos IS
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):108-11. PubMed ID: 18162230
[TBL] [Abstract][Full Text] [Related]
3. International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma.
Mu S; Shi D; Ai L; Fan F; Peng F; Sun C; Hu Y
Front Immunol; 2021; 12():732006. PubMed ID: 34745101
[TBL] [Abstract][Full Text] [Related]
4. High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma.
Hou Y; Wang HQ; Ba Y
Med Oncol; 2012 Dec; 29(5):3498-503. PubMed ID: 22528513
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma.
Wang WL; Yang C; Han XL; Wang R; Huang Y; Zi YM; Li JD
Med Oncol; 2014 Apr; 31(4):919. PubMed ID: 24659264
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients.
Hu M; Wang X; Liu N; Ding K; Zhang G; Liu X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34109978
[TBL] [Abstract][Full Text] [Related]
7. Prognostic biomarkers in diffuse large B-cell lymphoma.
Lossos IS; Morgensztern D
J Clin Oncol; 2006 Feb; 24(6):995-1007. PubMed ID: 16418498
[TBL] [Abstract][Full Text] [Related]
8. Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP.
Green TM; Jensen AK; Holst R; Falgreen S; Bøgsted M; de Stricker K; Plesner T; Mourits-Andersen T; Frederiksen M; Johnsen HE; Pedersen LM; Møller MB
Br J Haematol; 2016 Sep; 174(6):876-86. PubMed ID: 27196819
[TBL] [Abstract][Full Text] [Related]
9. Molecular Subtyping of Diffuse Large B-Cell Lymphoma Using a Novel Quantitative RT-PCR Assay.
Ta R; Santini C; Gou P; Lee G; Tai YC; O'Brien C; Fontecha M; Grant C; Bacon L; Finn S; Vandenberghe E; Quinn F; Dua R; Flavin R
J Mol Diagn; 2021 Mar; 23(3):323-340. PubMed ID: 33385586
[TBL] [Abstract][Full Text] [Related]
10. Emerging prognostic factors in diffuse large B cell lymphoma.
Gascoyne RD
Curr Opin Oncol; 2004 Sep; 16(5):436-41. PubMed ID: 15314511
[TBL] [Abstract][Full Text] [Related]
11. Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
Alizadeh AA; Gentles AJ; Alencar AJ; Liu CL; Kohrt HE; Houot R; Goldstein MJ; Zhao S; Natkunam Y; Advani RH; Gascoyne RD; Briones J; Tibshirani RJ; Myklebust JH; Plevritis SK; Lossos IS; Levy R
Blood; 2011 Aug; 118(5):1350-8. PubMed ID: 21670469
[TBL] [Abstract][Full Text] [Related]
12. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
14. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
[TBL] [Abstract][Full Text] [Related]
15. The importance of Myd88 L265P mutation, clinical and immunohistochemical prognostic factors for the survival of patients with diffuse large B-cell non-Hodgkin lymphoma treated by immunochemotherapy in southeast Serbia.
Tadic L; Marjanovic G; Macukanovic-Golubovic L; Krstic M; Jevtovic-Stoimenov T; Kostov M; Smelcerovic Z; Stojanovic M
J BUON; 2016; 21(5):1259-1267. PubMed ID: 27837631
[TBL] [Abstract][Full Text] [Related]
16. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
Shen Y; Wang L; Ou J; Wang B; Cen X
Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
[No Abstract] [Full Text] [Related]
17. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
Lossos IS; Jones CD; Warnke R; Natkunam Y; Kaizer H; Zehnder JL; Tibshirani R; Levy R
Blood; 2001 Aug; 98(4):945-51. PubMed ID: 11493437
[TBL] [Abstract][Full Text] [Related]
18. miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.
Montes-Moreno S; Martinez N; Sanchez-Espiridión B; Díaz Uriarte R; Rodriguez ME; Saez A; Montalbán C; Gomez G; Pisano DG; García JF; Conde E; Gonzalez-Barca E; Lopez A; Mollejo M; Grande C; Martinez MA; Dunphy C; Hsi ED; Rocque GB; Chang J; Go RS; Visco C; Xu-Monette Z; Young KH; Piris MA
Blood; 2011 Jul; 118(4):1034-40. PubMed ID: 21633089
[TBL] [Abstract][Full Text] [Related]
19. The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients.
Shizusawa T; Shibayama H; Murata S; Saitoh Y; Sugimoto Y; Matsumura I; Ogawa H; Sugiyama H; Fukuhara S; Hino M; Kanamaru A; Yamauchi A; Aozasa K; Kanakura Y
Leuk Lymphoma; 2008 Jan; 49(1):113-21. PubMed ID: 18203020
[TBL] [Abstract][Full Text] [Related]
20. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.
Culpin RE; Proctor SJ; Angus B; Crosier S; Anderson JJ; Mainou-Fowler T
Int J Oncol; 2010 Aug; 37(2):367-76. PubMed ID: 20596664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
